Pierre Laurin

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 20 CIPO patents and 4 EPO patents. Top assignees: Prometic Pharma Smt Limited, Prometic Biosciences Inc., Liminal Biosciences Limited. Active years: 2010-2023.

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 20 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Quebec, CA (2010 - 2017)
Ville Mont-Royal, CA (2015 - 2023)

Company Filing History:

7 out of 12

Prometic Pharma Smt Limited

patents

5 out of 30

Prometic Biosciences Inc.

patents

2 out of 6

Liminal Biosciences Limited

patents

4. 2 out of 5

Prometic Biotherapeutics, Inc.

patents

Years Active: 2010-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11826404 - Plasminogen treatment of conditions associated with PAI-1 overexpression (2023-11-28),

2. 11524930 - Substituted aromatic compounds and related method for the treatment of fibrosis (2022-12-13),

3. 11291711 - Plasminogen replacement therapy for plasminogen-deficiency (2022-04-05),

4. 11267779 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2022-03-08),

5. 10869849 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2020-12-22),

6. 10550066 - Substituted aromatic compounds and related method for the treatment of fibrosis (2020-02-04),

7. 10450258 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2019-10-22),

8. 10391073 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2019-08-27),

9. 10023518 - Substituted aromatic compounds and related method for the treatment of fibrosis (2018-07-17),

10. 9884802 - Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2018-02-06),

11. 9682054 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis (2017-06-20),

12. 9475750 - Phenylketone carboxylate compounds and pharmaceutical uses thereof (2016-10-25),

13. 9439882 - Compounds and compositions for the treatment of cancer (2016-09-13),

14. 9114118 - Compounds and compositions for the treatment of cancer (2015-08-25),

15. 8487001 - Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors (2013-07-16),

Title: Top Inventor in Ville Mont-Royal, Canada: Pierre-Michel D'Anglade

Introduction: Pierre-Michel D'Anglade is a prominent inventor based in Ville Mont-Royal, Canada. His contributions to the field of innovation have garnered significant attention and respect.

Latest Patents: D'Anglade has recently been awarded several patents that showcase his inventive prowess and commitment to advancing technology.

Career Highlights: Throughout his career, Pierre-Michel has achieved numerous milestones that highlight his expertise and dedication to innovation.

Collaborations: He has collaborated with various organizations and individuals, further enhancing his impact on the industry.

Conclusion: Pierre-Michel D'Anglade continues to be a leading figure in the world of invention, inspiring future generations of innovators.